Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Venice’s newest marvel is a wild, acrobatic dolphin. His refusal to leave puts him in danger - 2Understanding the Rudiments of Tree Administrations
- 3The year's first meteor shower and supermoon clash in January skies
- 4High Court freezes government move to shutter Army Radio pending ruling
- 5Creative Style: 10 Architects Reclassifying the Business
- SpaceX launches Italian Earth-observing satellite to orbit on the 1st mission of 2026 (video)
- Vote in favor of your Number one Kind of Shades
- Ancient eggshells shed new light on crocodiles that hunted prey from trees
- Artemis 2 moon astronauts will try to recreate Apollo 8's historic 'Earthrise' photo during April 6 flyby
- Nestlé says 413,793 KitKat candy bars stolen en route from Italy to Poland
- Find the Marvels of the World with These Travels
- New movies to watch this weekend: See 'The Drama' in theaters, rent 'Wuthering Heights,' stream 'Pizza Movie' on Hulu
- ‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- Inside Plan with Houseplants: An Aide
